We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The year 2020 has proven to be a defining year for the medical and biopharmaceutical fields across the world. Since the first half of the year, many countries across the world have been plagued with the COVID-19 pandemic.
Researchers from Statens Serum Institut (SSI), Denmark, and Imperial College London have published promising results from the first clinical trial of a vaccine for Chlamydia, the most common sexually transmitted disease.